PT1121108E - Nova utilizacao terapeutica de compostos com actividade beta-3-agonista - Google Patents

Nova utilizacao terapeutica de compostos com actividade beta-3-agonista

Info

Publication number
PT1121108E
PT1121108E PT99946255T PT99946255T PT1121108E PT 1121108 E PT1121108 E PT 1121108E PT 99946255 T PT99946255 T PT 99946255T PT 99946255 T PT99946255 T PT 99946255T PT 1121108 E PT1121108 E PT 1121108E
Authority
PT
Portugal
Prior art keywords
compounds
agonist activity
beta
new therapeutic
therapeutic utilization
Prior art date
Application number
PT99946255T
Other languages
English (en)
Inventor
Charles Advenier
Luciano Manara
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PT1121108E publication Critical patent/PT1121108E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT99946255T 1998-10-14 1999-09-29 Nova utilizacao terapeutica de compostos com actividade beta-3-agonista PT1121108E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812877A FR2784582B3 (fr) 1998-10-14 1998-10-14 Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste

Publications (1)

Publication Number Publication Date
PT1121108E true PT1121108E (pt) 2003-08-29

Family

ID=9531553

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99946255T PT1121108E (pt) 1998-10-14 1999-09-29 Nova utilizacao terapeutica de compostos com actividade beta-3-agonista

Country Status (11)

Country Link
US (1) US6310050B1 (pt)
EP (1) EP1121108B1 (pt)
JP (1) JP2002527377A (pt)
AT (1) ATE235899T1 (pt)
AU (1) AU5868699A (pt)
DE (1) DE69906558T2 (pt)
DK (1) DK1121108T3 (pt)
ES (1) ES2195612T3 (pt)
FR (1) FR2784582B3 (pt)
PT (1) PT1121108E (pt)
WO (1) WO2000021508A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
EP1514869A1 (en) * 2002-06-12 2005-03-16 Sumitomo Pharmaceuticals Company, Limited Indole, indazole, and benzazole derivative
US10350167B2 (en) * 2013-05-23 2019-07-16 The University Of Newcastle Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodies
CA3193201A1 (en) 2014-05-06 2015-11-12 Anthony G. Visco Methods of treating or preventing preterm labor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65511B1 (en) * 1989-12-29 1995-11-01 Sanofi Sa New phenylethanolaminomethyltetralins
EP0627407A1 (fr) 1993-05-28 1994-12-07 MIDY S.p.A. Acide (7S)-7-[(2R)-2(3-chlorophényl)-2-hydroxyéthylamino]-5,6,7,8-tétrahydronaphtalèn-2-yloxy acétique, ses sels pharmaceutiquement acceptables, à action agoniste bêta-3 adrénergique et compositions pharmaceutiques le contenant

Also Published As

Publication number Publication date
DK1121108T3 (da) 2003-07-21
US6310050B1 (en) 2001-10-30
AU5868699A (en) 2000-05-01
JP2002527377A (ja) 2002-08-27
EP1121108A2 (fr) 2001-08-08
EP1121108B1 (fr) 2003-04-02
DE69906558D1 (de) 2003-05-08
FR2784582A1 (fr) 2000-04-21
ES2195612T3 (es) 2003-12-01
WO2000021508A2 (fr) 2000-04-20
FR2784582B3 (fr) 2000-11-24
DE69906558T2 (de) 2004-02-26
ATE235899T1 (de) 2003-04-15
WO2000021508A3 (fr) 2000-10-26

Similar Documents

Publication Publication Date Title
GB9818916D0 (en) Use
HK1031884A1 (en) Prostaglandin agonists and their use to treat bonedisorders.
HK1051041A1 (en) Quinazoline ditosylate salt compounds
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
MY117805A (en) Resorcinol derivatives
DE69533697D1 (de) ANTISENSE OLIGONUKLEOTIDMODULATION DER raf GENEXPRESSION
BG102644A (en) Improved concentrated inoculation and infusion solutions for intravasal application
AU3831301A (en) Method for treating ocular pain
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
HK1068274A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
MY121523A (en) Resorcinol derivatives
MY136261A (en) Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
DE69904098D1 (de) Verwendung niedrig legierter Stähle, die nicht zur Koksbildung neigen
PT1121108E (pt) Nova utilizacao terapeutica de compostos com actividade beta-3-agonista
EP0992243A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
TR200003084T2 (tr) Paroxetine askorbat
GR20010100390A (el) Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων.
NO20012169D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
DE50012015D1 (de) Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs
TR200000176T2 (tr) Propilen oksidin saflaştırılması.
PL356931A1 (en) Use of natural compounds having antiangiogenic activity
SE9802075D0 (sv) New use
IT1305242B1 (it) Preparatore di mazzi di pelli.